as been an ongoing catalyst for IT companies, IdeasProject wants to deposit those themes into the human dialogue to facilitate understanding, discussion and innovation around the globe. We're honored that our charter contributors like Esther, share their wealth of knowledge, inspire the world and enrich the pool of big ideas."
For the next three months, visitors to ideasproject.com have the opportunity to submit their own Big Idea. Editors will be regularly highlighting their favorite ideas, and sending a Nokia N95 to the Big Thinker who was selected. We'll also be featuring our favorite visitor-contributed Big Ideas along with the ideas of other ideasproject.com contributors.
About Esther Dyson:
Esther Dyson is a long-time catalyst of start-ups in information technology in the U.S. and other markets, including Russia. Since selling her company, EDventure Holdings, to CNET Networks in 2004, she has taken on newer challenges in private aviation and space as well as in health care (as a director of 23andMe, a consumer genetics company). Her IT investments have included Flickr and del.icio.us (both sold to Yahoo!), and Medstory (sold to Microsoft), as well as Meetup Inc., Eventful.com, Boxbe and Voxiva. She is also an active investor in air and space, with holdings in Space Adventures and Zero-G Corporation, as well as XCOR Aerospace, Constellation Services International, Coastal Technologies Group, Dopplr.com, Airship Ventures and Icon Aircraft.
IdeasProject, a project of Nokia hosted at www.ideasproject.com, brings together the most visionary and influenti
Page: 1 2 3 Related biology technology :1
Copyright©2009 Vocus, Inc.
All rights reserved
. BioMed Realty Trust Announces New Financing for Joint Venture With Prudential Real Estate Investors2
. GeoVax Update Provided at the BIO CEO & Investor Conference 20093
. Transcept Pharmaceuticals to Present at 11th Annual BIO CEO & Investor Conference4
. In Analyst Interview, Cord Blood America Says Stem Cells Now Front and Center for Researchers and Investors5
. BioMS Medical to present at BIO CEO and Investor Conference6
. Micromet to Present at the BIO CEO and Investor Conference on February 10, 20097
. Orexigen(R) Therapeutics to Speak at BIO CEO & Investor Conference8
. NeurogesX to Present at 11th Annual BIO CEO & Investor Conference9
. Sunesis to Present at the 11th Annual BIO CEO & Investor Conference10
. Monsanto Executives to Discuss Companys Growth Drivers, Profit Goals at Investor Conferences in February11
. GeoVax to Webcast Its Presentation at the BIO CEO & Investor 2009 Conference